HIGHLIGHTS
- who: Ghazaleh Khalili-Tanha from the Department of Medical University of Medical Sciences, Mashhad, Iran have published the article: Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells, in the Journal: (JOURNAL)
- what: Against conventional chemotherapeutic agents is one of the main reasons for tumor relapse and poor clinical outcomes in patients.
SUMMARY
By causing DNA damage that prevents mitosis in tumor cells. Despite its wide clinical application, DOX is a double-edged sword: it damages normal tissues, thus negatively affecting the quality of patients' lives . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.